US 11020417
Methods and compounds for treatment of lymphocyte-related diseases and conditions
granted A61KA61K31/675A61K31/7125
Quick answer
US patent 11020417 (Methods and compounds for treatment of lymphocyte-related diseases and conditions) held by Sarepta Therapeutics, Inc. expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/675, A61K31/7125, A61P, A61P35/00